Aug 11 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* CENTURY THERAPEUTICS INC - ENDED Q2 2022 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $429.4; EXPECTED CASH RUNWAY
INTO 2025
* CENTURY THERAPEUTICS INC - EXPECTS FULL YEAR GAAP
OPERATING
EXPENSES TO BE BETWEEN $155 MILLION AND $165 MILLION
* CENTURY THERAPEUTICS INC - NET LOSS WAS $31.0 MILLION FOR
THREE
MONTHS ENDED JUNE 30, 2022, COMPARED TO $23.3 MILLION FOR SAME
PERIOD IN 2021
Source text for Eikon: ID:nGNX9fgJLW
Further company coverage: IPSC.O
((reuters.briefs@thomsonreuters.com;))